These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27028759)

  • 1. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial.
    Palacio M; Cobo T; Antolín E; Ramirez M; Cabrera F; Mozo de Rosales F; Bartha JL; Juan M; Martí A; Oros D; Rodríguez À; Scazzocchio E; Olivares JM; Varea S; Ríos J; Gratacós E;
    BJOG; 2016 Nov; 123(12):1990-1999. PubMed ID: 27028759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of vaginal progesterone as a maintenance therapy in women with arrested preterm labor: a double-blind placebo-randomized controlled trial.
    Hyett J; Asadi N; Zare Khafri M; Vafaei H; Kasraeian M; Salehi A; Saadati N; Bazrafshan K
    J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1134-1140. PubMed ID: 32216490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
    Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J
    Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.
    Vermeulen GM; Bruinse HW
    Br J Obstet Gynaecol; 1999 Jul; 106(7):652-7. PubMed ID: 10428520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
    Brizot ML; Hernandez W; Liao AW; Bittar RE; Francisco RPV; Krebs VLJ; Zugaib M
    Am J Obstet Gynecol; 2015 Jul; 213(1):82.e1-82.e9. PubMed ID: 25731690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A
    BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.
    Dodd JM; Crowther CA; McPhee AJ; Flenady V; Robinson JS
    BMC Pregnancy Childbirth; 2009 Feb; 9():6. PubMed ID: 19239712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Suhag A; Saccone G; Berghella V
    Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K; Rode L; Nicolaides KH; Krampl-Bettelheim E; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial.
    Landman AJEMC; de Boer MA; Visser L; Nijman TAJ; Hemels MAC; Naaktgeboren CN; van der Weide MC; Mol BW; van Laar JOEH; Papatsonis DNM; Bekker MN; van Drongelen J; van Pampus MG; Sueters M; van der Ham DP; Sikkema JM; Zwart JJ; Huisjes AJM; van Huizen ME; Kleiverda G; Boon J; Franssen MTM; Hermes W; Visser H; de Groot CJM; Oudijk MA
    PLoS Med; 2022 Feb; 19(2):e1003892. PubMed ID: 35104279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vaginal progesterone in tocolytic therapy during preterm labor in twin pregnancies: Secondary analysis of a placebo-controlled randomized trial.
    Hernandez WR; Francisco RPV; Bittar RE; Gomez UT; Zugaib M; Brizot ML
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1536-1542. PubMed ID: 28707771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.